Assessment of Urinary Betaine as a Marker of Diabetes Mellitus in Cardiovascular Patients

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Schartum Hansen, Hall ^a,b   Ueland, Per M ^a,b   Pedersen, Eva R ^a   Meyer, Klaus ^c   Ebbing, Marta ^b   Bleie, Øyvind ^b   Svingen, Gard F T ^a   Seifert, Reinhard ^b   Vikse, Bjørn E ^a,b   Nygård, Ottar ^a,b  

^a UNIVERSITY OF BERGEN   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^c BEVITAL AS   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

BETAINE; CYANOCOBALAMIN; FOLIC ACID; GLUCOSE; HEMOGLOBIN A1C; HOMOCYSTEINE;

ADULT; AGE; AGED; ARTICLE; CARDIOVASCULAR DISEASE; DIABETES MELLITUS; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HUMAN; ISCHEMIC HEART DISEASE; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; TANDEM MASS SPECTROMETRY; TEST RETEST RELIABILITY; URINARY EXCRETION;

AGED; BETAINE; BIOLOGICAL MARKERS; BLOOD GLUCOSE; CARDIOVASCULAR DISEASES; DIABETES COMPLICATIONS; DIABETES MELLITUS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GLOMERULAR FILTRATION RATE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; VITAMIN B COMPLEX;

EID: 84881138347     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0069454     Document Type: Article

References (37)

1. Lever M, George PM, Dellow WJ, Scott RS, Chambers ST, (2005) Homocysteine, glycine betaine, and N,N-dimethylglycine in patients attending a lipid clinic. Metabolism 54: 1-14.
2. Konstantinova SV, Tell GS, Vollset SE, Nygard O, Bleie O, et al. (2008) Divergent associations of plasma choline and betaine with components of metabolic syndrome in middle age and elderly men and women. J Nutr 138: 914-920.
3. Lever M, Sizeland PC, Bason LM, Hayman CM, Robson RA, et al. (1994) Abnormal glycine betaine content of the blood and urine of diabetic and renal patients. Clin Chim Acta 230: 69-79.
4. Dellow WJ, Chambers ST, Lever M, Lunt H, Robson RA, (1999) Elevated glycine betaine excretion in diabetes mellitus patients is associated with proximal tubular dysfunction and hyperglycemia. Diabetes Res Clin Pract 43: 91-99.
5. Lever M, Sizeland PC, Frampton CM, Chambers ST, (2004) Short and long-term variation of plasma glycine betaine concentrations in humans. Clin Biochem 37: 184-190.
6. Lever M, Atkinson W, George PM, Chambers ST, (2007) An abnormal urinary excretion of glycine betaine may persist for years. Clin Biochem 40: 798-801.
7. Lever M, Atkinson W, Slow S, Chambers ST, George PM, (2009) Plasma and urine betaine and dimethylglycine variation in healthy young male subjects. Clin Biochem 42: 706-712.
8. Lin CS, Wu RD, (1986) Choline Oxidation and Choline Dehydrogenase. Journal of Protein Chemistry 5: 193-200.
9. Lever M, Sizeland PC, Bason LM, Hayman CM, Chambers ST, (1994) Glycine betaine and proline betaine in human blood and urine. Biochim Biophys Acta 1200: 259-264.
10. Wunz TM, Wright SH, (1993) Betaine transport in rabbit renal brush-border membrane vesicles. Am J Physiol 264: F948-955.
11. Pummer S, Dantzler WH, Lien YH, Moeckel GW, Volker K, et al. (2000) Reabsorption of betaine in Henle's loops of rat kidney in vivo. Am J Physiol Renal Physiol 278: F434-439.
12. Lang F, (2007) Mechanisms and significance of cell volume regulation. J Am Coll Nutr 26: 613S-623S.
13. Ueland PM, Holm PI, Hustad S, (2005) Betaine: a key modulator of one-carbon metabolism and homocysteine status. Clin Chem Lab Med 43: 1069-1075.
14. Wijekoon EP, Hall B, Ratnam S, Brosnan ME, Zeisel SH, et al. (2005) Homocysteine metabolism in ZDF (type 2) diabetic rats. Diabetes 54: 3245-3251.
15. Pajares MA, Perez-Sala D, (2006) Betaine homocysteine S-methyltransferase: just a regulator of homocysteine metabolism? Cell Mol Life Sci 63: 2792-2803.
16. Ebbing M, Bleie O, Ueland PM, Nordrehaug JE, Nilsen DW, et al. (2008) Mortality and cardiovascular events in patients treated with homocysteine-lowering B vitamins after coronary angiography: a randomized controlled trial. JAMA 300: 795-804.
17. Conti M, Moutereau S, Esmilaire L, Desbene C, Lallali K, et al. (2009) Should kidney tubular markers be adjusted for urine creatinine? The example of urinary cystatin C. Clin Chem Lab Med 47: 1553-1556.
18. Shemesh O, Golbetz H, Kriss JP, Myers BD, (1985) Limitations of creatinine as a filtration marker in glomerulopathic patients. Kidney Int 28: 830-838.
19. Levey AS, Stevens LA, Schmid CH, Zhang YP, Castro AF, et al. (2009) A New Equation to Estimate Glomerular Filtration Rate. Annals of Internal Medicine 150: 604-U607.
20. Holm PI, Ueland PM, Kvalheim G, Lien EA, (2003) Determination of choline, betaine, and dimethylglycine in plasma by a high-throughput method based on normal-phase chromatography-tandem mass spectrometry. Clin Chem 49: 286-294.
21. Windelberg A, Arseth O, Kvalheim G, Ueland PM, (2005) Automated assay for the determination of methylmalonic acid, total homocysteine, and related amino acids in human serum or plasma by means of methylchloroformate derivatization and gas chromatography-mass spectrometry. Clin Chem 51: 2103-2109.
22. Biroccio A, Urbani A, Massoud R, di Ilio C, Sacchetta P, et al. (2005) A quantitative method for the analysis of glycated and glutathionylated hemoglobin by matrix-assisted laser desorption ionization-time of flight mass spectrometry. Anal Biochem 336: 279-288.
23. Nathan DM, Nathan DM, Balkau B, Bonora E, Borch-Johnsen K, et al. (2009) International Expert Committee Report on the Role of the A1C Assay in the Diagnosis of Diabetes. Diabetes Care 32: 1327-1334.
24. Lever M, George PM, Slow S, Elmslie JL, Scott RS, et al. (2009) Fibrates may Cause an Abnormal Urinary Betaine Loss Which is Associated with Elevations in Plasma Homocysteine. Cardiovascular Drugs and Therapy 23: 395-401.
25. Lever M, Slow S, McGregor DO, Dellow WJ, George PM, et al. (2012) Variability of plasma and urine betaine in diabetes mellitus and its relationship to methionine load test responses: an observational study. Cardiovasc Diabetol 11: 34.
26. Gloyn AL, Faber JH, Malmodin D, Thanabalasingham G, Lam F, et al. (2012) Metabolic profiling in Maturity-onset diabetes of the young (MODY) and young onset type 2 diabetes fails to detect robust urinary biomarkers. PLoS One 7: e40962.
27. Lever M, George PM, Elmslie JL, Atkinson W, Slow S, et al. (2012) Betaine and secondary events in an acute coronary syndrome cohort. PLoS One 7: e37883.
28. Matheson A, Willcox MD, Flanagan J, Walsh BJ, (2010) Urinary biomarkers involved in type 2 diabetes: a review. Diabetes Metab Res Rev 26: 150-171.
29. Thomas MC, Burns WC, Cooper ME, (2005) Tubular changes in early diabetic nephropathy. Adv Chronic Kidney Dis 12: 177-186.
30. Quinones-Galvan A, Ferrannini E, (1997) Renal effects of insulin in man. J Nephrol 10: 188-191.
31. Neuhofer W, Beck FX, (2005) Cell survival in the hostile environment of the renal medulla. Annual Review of Physiology 67: 531-555.
32. Atkinson W, Downer P, Lever M, Chambers ST, George PM, (2007) Effects of orange juice and proline betaine on glycine betaine and homocysteine in healthy male subjects. Eur J Nutr 46: 446-452.
33. Padilla MC, Armas-Hernandez MJ, Hernandez RH, Israili ZH, Valasco M, (2007) Update of diuretics in the treatment of hypertension. Am J Ther 14: 154-160.
34. Lever M, Atkinson W, Sizeland PC, Chambers ST, George PM, (2007) Inter- and intra-individual variations in normal urinary glycine betaine excretion. Clin Biochem 40: 447-453.
35. Inzucchi SE, (2012) Clinical practice. Diagnosis of diabetes. N Engl J Med 367: 542-550.
36. Stevens LA, Coresh J, Greene T, Levey AS, (2006) Assessing kidney function--measured and estimated glomerular filtration rate. N Engl J Med 354: 2473-2483.
37. Preiss D, Seshasai SR, Welsh P, Murphy SA, Ho JE, et al. (2011) Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis. JAMA 305: 2556-2564.